Virology. Frameshifting to PA-X influenza.

Twenty amino acids at the C-terminus of PA-X are associated with increased influenza A virus replication and pathogenicity. J Gen Virol (2015) 0.92

Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs. J Prev Med Hyg (2014) 0.86

Equine and Canine Influenza H3N8 Viruses Show Minimal Biological Differences Despite Phylogenetic Divergence. J Virol (2015) 0.82

Partial and full PCR-based reverse genetics strategy for influenza viruses. PLoS One (2012) 0.81

FLDS: A Comprehensive dsRNA Sequencing Method for Intracellular RNA Virus Surveillance. Microbes Environ (2016) 0.79

Why does pandemic influenza virus kill? Am J Pathol (2013) 0.78

Truncation of C-terminal 20 amino acids in PA-X contributes to adaptation of swine influenza virus in pigs. Sci Rep (2016) 0.77

Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression. J Virol (2015) 0.75

A novel influenza A virus mitochondrial protein that induces cell death. Nat Med (2001) 9.90

Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe (2007) 5.46

Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol (2006) 4.74

Tissue-specific differences in human transfer RNA expression. PLoS Genet (2006) 4.10

Ribosomal frameshifting in the yeast retrotransposon Ty: tRNAs induce slippage on a 7 nucleotide minimal site. Cell (1990) 3.87

An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science (2012) 3.70

Prevalence of epistasis in the evolution of influenza A surface proteins. PLoS Genet (2011) 2.41

Individual expression of influenza virus PA protein induces degradation of coexpressed proteins. J Virol (1995) 2.02

Influenza A virus polymerase: structural insights into replication and host adaptation mechanisms. J Biol Chem (2010) 1.89

Current knowledge on PB1-F2 of influenza A viruses. Med Microbiol Immunol (2010) 1.12

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J Clin Oncol (2005) 9.95

Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-{gamma}c-/- mouse. J Virol (2009) 1.41

Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy. Proc Natl Acad Sci U S A (2011) 1.40

Most influenza a virions fail to express at least one essential viral protein. J Virol (2013) 1.14

Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection. Cell Host Microbe (2013) 1.13

Identification and recovery of minor HIV-1 variants using the heteroduplex tracking assay and biotinylated probes. Nucleic Acids Res (2008) 0.83

Greasing the SCIDs for universal flu antibodies. Cell Host Microbe (2013) 0.75